CV Sciences (OTCMKTS:CVSI) Lowered to “Hold” at Zacks Investment Research

by Newsfeed


Zacks Investment Research lowered shares of CV Sciences (OTCMKTS:CVSI) from a buy rating to a hold rating in a research report released on Friday morning, Zacks.com reports.

According to Zacks, “CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States. “

A number of other analysts have also recently weighed in on CVSI. ValuEngine cut…



Read Full Article Here

save 80% off #1 trusted top selling CBD and Hemp P

You may also like